Pilot Studies in Pancreatic Cancer
The summary for the Pilot Studies in Pancreatic Cancer grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Pilot Studies in Pancreatic Cancer: - This funding opportunity is intended to promote innovative research across multiple disciplines for better understanding of the biology, etiology, detection, prevention, and treatment of pancreatic cancer. - Examples of appropriate research areas include, but are not limited to: Identification of genetic aberrations (e.g., mutations, epigenetic changes, etc.) or combinations of aberrations alterations that initiate or promote pancreatic cancer; Development of experimental models for human pancreatic cancer to facilitate the understanding of molecular carcinogenesis, to help to identify promising molecular targets, and to test new preventive/therapeutic strategies; Exploration of molecular pathways using human cell lines and/or tissues to identify possible novel targets for prevention or therapeutic development; Identification of markers for early detection of cancer; Conduct of preclinical studies to identify candidate chemopreventive drug(s) and dietary factors for prevention and to characterize the molecular mechanism(s) of the agent's activity; Conduct of small exploratory clinical trials with a potential chemopreventive agent (e.g., a farnesyltransferase inhibitor or a sta! tin) assessing response via endoscopic ultrasound or another similar technology; Development of early-stage clinical trials in pancreatic cancer prevention and therapy; Assessment of any associations of tumor pathophysiology on tumor development, progression, and preventive/therapeutic response; Conduct of exploratory studies to identify and evaluate biomarkers (with associated assay development) to determine prognosis and predict response to therapy in pancreatic cancer; Evaluation of combination therapies for pancreatic cancer; Identification of new' environmental exposures (e.g., adverse energy balance) that may contribute to pancreatic cancer development, including adverse energy balance; Assessment of the impact of pancreatic cancer on health-related quality of life of patients and their caregivers; and Conduct of pilot surveillance studies and generation of survivorship registries. - Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received. - This PA involves use of the R03 and R21 mechanisms. The R03 mechanism supports small research projects that can be carried out in a short period of time with limited resources. The R21 mechanism is intended to encourage new exploratory and developmental research projects. As an applicant, you will be solely responsible for planning, directing, and executing the proposed project. - You may submit (an) application(s) if your organization has any of the following characteristics: For-profit organizations; Non-profit organizations; Public or private institutions, such as universities, colleges, hospitals, and laboratories; Units of State or local governments; Eligible agencies of the Federal government; Domestic Institutions; Foreign Institutions; and/or Faith-based or community-based organizations. - Applicants may submit more than one application, provided that they are scientifically distinct. - See Section IV for application and submission information. - Telecommunications for the hearing impaired is available at: TTY 301-451-0088
|Federal Grant Title:||Pilot Studies in Pancreatic Cancer|
|Federal Agency Name:||National Institutes of Health|
|Grant Categories:||Education Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||PA-05-116|
|Type of Funding:||Grant|
|CFDA Descriptions:||Cancer Cause and Prevention Research|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Multiple Receipt Dates - See Link to Full Announce|
|Posted Date:||May 26, 2005|
|Creation Date:||May 26, 2005|
|Archive Date:||Jun 02, 2006|
|Total Program Funding:|
|Maximum Federal Grant Award:|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Private institutions of higher education Special district governments For profit organizations other than small businesses County governments Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education State governments Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification) Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Additional Information on Eligibility
- Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are eligible to apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
- Similar Government Grants
- • Coordinating Center for Canine Immunotherapy Trials and Correlative Studies (U24)
- • Canine Immunotherapy Trials and Correlative Studies (U01)
- • Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical S...
- • Revision Applications for U.S.-South Africa Program for Collaborative Biomedical Research ...
- • NCI Research Specialist (laboratory-based Scientist) Award (R50)
- • Cancer Prevention Research Small Grant Program
- • Molecular Targets for Nutrients in Prostate Cancer Prevention
- • Cancer Prevention Research Small Grant Program (R03)
- More Grants from the National Institutes of Health
- • Limited Competition for NIH-Industry Program: Discovering Pediatric New Therapeutic Uses f...
- • Environmental influences on Placental Origins of Development (ePOD) (R01)
- • Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existin...
- • Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existin...
- • Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01)